Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 42,134,540 | 40,921,380 | 38,407,870 | 38,709,660 | 45,341,090 |
| Cost of Goods | 13,504,740 | 13,123,910 | 11,842,830 | 12,124,460 | 14,660,850 |
| Gross Profit | 28,629,800 | 27,797,470 | 26,565,040 | 26,585,200 | 30,680,240 |
| Operating Expenses | 22,398,400 | 20,728,360 | 18,973,490 | 19,547,940 | 22,146,990 |
| Operating Income | 6,232,137 | 7,070,027 | 7,592,383 | 7,037,719 | 8,534,105 |
| Interest Expense | 513,735 | 474,726 | 1,022,498 | 620,714 | 804,227 |
| Other Income | 73,222 | -227,191 | -138,326 | -619,607 | -179,455 |
| Pre-tax Income | 5,791,624 | 6,368,110 | 6,431,559 | 5,797,398 | 7,550,424 |
| Income Tax | 568,061 | 1,946,377 | 1,467,352 | 787,274 | 1,556,610 |
| Net Income Continuous | 5,223,563 | 4,421,734 | 4,964,208 | 5,010,125 | 5,993,813 |
| Minority Interests | 122,824 | 136,766 | 100,701 | 112,150 | 158,187 |
| Net Income | $5,100,739 | $4,284,967 | $4,863,507 | $4,897,975 | $5,835,627 |
| EPS Basic Total Ops | 2.04 | 3.79 | 2.03 | 1.82 | 2.22 |
| EPS Basic Continuous Ops | 2.09 | 1.76 | 1.93 | 1.92 | 2.28 |
| EPS Diluted Total Ops | 2.03 | 3.76 | 2.01 | 1.81 | 2.19 |
| EPS Diluted Continuous Ops | 2.08 | 1.75 | 1.92 | 1.90 | 2.25 |
| EPS Diluted Before Non-Recurring Items | 3.23 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $11,285,640 | $11,236,310 | $11,245,270 | $11,785,790 | $13,554,870 |